During the corresponding time, Yield10 Bioscience Inc sequentially revenue grew by 50 %. While revenue at the Yield10 Bioscience Inc 's corporate clients
Yield10 Bioscience Inc's Comment on Sales, Marketing and Customers
The company primarily serves the aquafeed sector in Chile, Norway, and Scotland, focusing on farmed Atlantic Salmon aquaculture, which is projected to grow at a 4% compound annual growth rate through 2026. Fish oil, a key ingredient in salmon feed comprising up to 10% of the feed by weight, has an estimated annual consumption of 500,000 tons. The aquaculture industry depends on fish oil for omega-3 supply, although demand exceeds the sustainable supply from ocean-harvested fish. Fish oil is also used to produce refined and concentrated omega-3 oils and derivatives such as ethyl-EPA, which serves the human nutrition, nutraceutical, and pharmaceutical markets. Annual ethyl-EPA production is estimated between 10,000 and 14,000 tons, with a market value of approximately $1.6 billion, projected to increase to $3.4 billion by 2030. Additionally, there is growing demand for high-protein meal derived from Camelina seed processing for animal feed and food applications; this meal contains about 42% protein.
In an era marked by a burgeoning need for sustainable and scalable food sources, a recent collaboration between Yield10 Bioscience and Rothamsted Research signals a turning point in the production of omega-3 oils. These long-chain fatty acids, integral to human health, aquafeed, and pet nutrition, could soon see a transformative shift thanks to advances in genetic engineering. The exclusive global commercial license granted to Yield10 by Rothamsted Research aims to leverage cutting-edge biotechnological methods to produce omega-3 oils using engineered Camelina a versatile oilseed crop. A Breakthrough in Omega-3 Production The focus is primarily on Camelina sativa, an ancient oilseed plant known for its rob...
Yield10 Bioscience Receives Approval for Genome-Edited E3902 Camelina in CanadaWOBURN, Mass. - In a significant development for agricultural bioscience, Yield10 Bioscience, Inc. (Nasdaq:YTEN) announced that the Plant Biosafety Office (PBO) of the Canadian Food Inspection Agency (CFIA) has cleared the company s genome-edited E3902 Camelina sativa (Camelina) for planting in Canada. The PBO reviewed information on Yield10 s E3902 Camelina and determined that it is not a Plant with Novel Trait (PNT) and does not require a pre-market notification under Part V of the Seeds Regulations.E3902 Camelina is a game-changer for the agriculture industry, as it combines genome edits in three proprietary genetic traits - C3...
In a major breakthrough, Yield10 Biosciences, a Boston-based agricultural bioscience company, has received a green light from the United States Department of Agriculture s Animal and Plant Health Inspection Service (USDA-APHIS) to cultivate and breed their Omega-3 Camelina varieties in the United States. This approval marks a significant milestone for the company, paving the way for a large-scale production of omega-3 fatty acids derived from Camelina, a versatile oilseed plant.Camelina, also known as false flax or gold-of-pleasure, is an oil-rich plant that thrives in different climates and soil conditions. Yield10 Biosciences has spent years perfecting their proprietary Camelina varieties, which have been ...
Yield10 Bioscience Inc’s Comment on Sales, Marketing and Customers
The company primarily serves the aquafeed sector in Chile, Norway, and Scotland, focusing on farmed Atlantic Salmon aquaculture, which is projected to grow at a 4% compound annual growth rate through 2026. Fish oil, a key ingredient in salmon feed comprising up to 10% of the feed by weight, has an estimated annual consumption of 500,000 tons. The aquaculture industry depends on fish oil for omega-3 supply, although demand exceeds the sustainable supply from ocean-harvested fish. Fish oil is also used to produce refined and concentrated omega-3 oils and derivatives such as ethyl-EPA, which serves the human nutrition, nutraceutical, and pharmaceutical markets. Annual ethyl-EPA production is estimated between 10,000 and 14,000 tons, with a market value of approximately $1.6 billion, projected to increase to $3.4 billion by 2030. Additionally, there is growing demand for high-protein meal derived from Camelina seed processing for animal feed and food applications; this meal contains about 42% protein.
Sources:
Yield10 Bioscience inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Yield10 Bioscience inc’s corporate clients.
For your research, we’ve provided 9 tables on Yield10 Bioscience inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
